787 related articles for article (PubMed ID: 27913536)
1. Reversal of direct oral anticoagulants: a practical approach.
Shih AW; Crowther MA
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):612-619. PubMed ID: 27913536
[TBL] [Abstract][Full Text] [Related]
2. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
Tummala R; Kavtaradze A; Gupta A; Ghosh RK
Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776
[TBL] [Abstract][Full Text] [Related]
3. Monitoring and reversal of direct oral anticoagulants.
Cuker A; Siegal D
Hematology Am Soc Hematol Educ Program; 2015; 2015():117-24. PubMed ID: 26637710
[TBL] [Abstract][Full Text] [Related]
4. How can we reverse bleeding in patients on direct oral anticoagulants?
Crowther M; Cuker A
Kardiol Pol; 2019; 77(1):3-11. PubMed ID: 30338501
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic Reversal of Direct Oral Anticoagulants.
Farina N; Miller JT
Crit Care Nurs Q; 2018; 41(2):121-128. PubMed ID: 29494368
[TBL] [Abstract][Full Text] [Related]
6. Idarucizumab and factor Xa reversal agents: role in hospital guidelines and protocols.
Huisman MV; Fanikos J
Am J Emerg Med; 2016 Nov; 34(11S):46-51. PubMed ID: 27697438
[TBL] [Abstract][Full Text] [Related]
7. Idarucizumab and Factor Xa Reversal Agents: Role in Hospital Guidelines and Protocols.
Huisman MV; Fanikos J
Am J Med; 2016 Nov; 129(11S):S89-S96. PubMed ID: 27569673
[TBL] [Abstract][Full Text] [Related]
8. Discontinuation and Management of Direct-Acting Anticoagulants for Emergency Procedures.
Levy JH
Am J Med; 2016 Nov; 129(11S):S47-S53. PubMed ID: 27569675
[TBL] [Abstract][Full Text] [Related]
9. Management of Elective Surgery and Emergent Bleeding with Direct Oral Anticoagulants.
Kaatz S; Mahan CE; Nakhle A; Gunasekaran K; Ali M; Lavender R; Paje DG
Curr Cardiol Rep; 2017 Oct; 19(12):124. PubMed ID: 29064044
[TBL] [Abstract][Full Text] [Related]
10. Universal, class-specific and drug-specific reversal agents for the new oral anticoagulants.
Ansell JE
J Thromb Thrombolysis; 2016 Feb; 41(2):248-52. PubMed ID: 26449414
[TBL] [Abstract][Full Text] [Related]
11. Reversal agents for direct oral anticoagulants: considerations for hospital physicians and intensivists.
Desai NR; Cornutt D
Hosp Pract (1995); 2019 Aug; 47(3):113-122. PubMed ID: 31317796
[TBL] [Abstract][Full Text] [Related]
12. [Management of bleeding associated with direct oral anticoagulants: update on reversal strategies].
Enríquez A; Baranchuk A; Corbalán R
Rev Med Chil; 2019; 147(1):73-82. PubMed ID: 30848768
[TBL] [Abstract][Full Text] [Related]
13. [NOAC: Real-life data and the role of antidotes for the treatment of bleeding].
Darius H
Med Klin Intensivmed Notfmed; 2017 Mar; 112(2):99-104. PubMed ID: 28144725
[TBL] [Abstract][Full Text] [Related]
14. [Treatment with inhibitors of new oral direct anticoagulants in patients with severe bleedings or urgent surgical procedures. The new dabigatran antidote: the place of idarucizumab in clinical practice].
Boda Z
Orv Hetil; 2016 Mar; 157(12):443-50. PubMed ID: 26971644
[TBL] [Abstract][Full Text] [Related]
15. Reversal agents for non-vitamin K antagonist oral anticoagulants.
Levy JH; Douketis J; Weitz JI
Nat Rev Cardiol; 2018 May; 15(5):273-281. PubMed ID: 29345686
[TBL] [Abstract][Full Text] [Related]
16. Management of Bleeding With Non-Vitamin K Antagonist Oral Anticoagulants in the Era of Specific Reversal Agents.
Ruff CT; Giugliano RP; Antman EM
Circulation; 2016 Jul; 134(3):248-61. PubMed ID: 27436881
[TBL] [Abstract][Full Text] [Related]
17. Reversal of anticoagulants: an overview of current developments.
Greinacher A; Thiele T; Selleng K
Thromb Haemost; 2015 May; 113(5):931-42. PubMed ID: 25832311
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of reversal agents for direct oral anticoagulants.
Monagle S; Eikelboom JW; Ng KH; Bhagirath VC
Future Cardiol; 2017 Mar; 13(2):153-159. PubMed ID: 28198201
[TBL] [Abstract][Full Text] [Related]
19. Reversal strategies in patients treated with direct oral anticoagulants.
Gressenberger P
Vasa; 2019 Aug; 48(5):389-392. PubMed ID: 30719950
[No Abstract] [Full Text] [Related]
20. Reversal of Direct Oral Anticoagulants: Current Status and Future Directions.
Weitz JI
Semin Respir Crit Care Med; 2017 Feb; 38(1):40-50. PubMed ID: 28208197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
